Stay current on news from Wisconsin’s innovation community with these recent headlines:
—Bright Cellars, a monthly wine club that seeks to help its subscribers develop more sophisticated palates, said it raised a $2.8 million funding round. Participating investors included Chicago-based Cleveland... Read more »
Late last month, the University of Michigan-Dearborn unveiled a new autonomous shuttle project called MDAS.ai, in which students and faculty will build a driverless vehicle for low-speed, pedestrian-filled environments.
Made possible through a collective $100,000 contribution from Osram Opto Semiconductors... Read more »
Austin—Ojo Labs, which is developing artificial intelligence-enabled chatbots designed for the real estate industry, has raised $20.5 million.
The new Series B funding round comes from investors such as Realogy Holdings, Royal Bank of Canada, Northwestern Mutual Future Ventures, and... Read more »
When it comes to advertising on the Web, Google remains king. But second-place Facebook has rapidly been narrowing the gap.
From 2012 to 2017, Facebook’s (NASDAQ: FB) ad revenues increased 833 percent, to $39.9 billion, according to Statista.com. That’s... Read more »
There’s nothing abstract about a 20 percent jump in a company’s stock price. But yeah, that happened to Loxo Oncology when it released data previews for its American Society for Clinical Oncology presentations; the meeting starts in two weeks in Chicago.... Read more »
The tech industry and the investment community that funds it are notorious for being, shall we say, safe spaces for white men.
The myth of meritocracy persists in the tech world even in the face of data indicating a longstanding... Read more »
The story of how genes are regulated has gotten a whole lot more complicated in recent years. Scientists, using ever-improving sequencing technologies, are discovering the many ways the cell can turn gene activity up or down. With this growing insight comes... Read more »
[Updated 5/18/18, 8:38 a.m. See below.] An Amgen migraine drug developed to head off pain before it starts has won FDA approval, the first for a new class of preventive drug candidates for the condition.
The Amgen (NASDAQ:... Read more »